Neuroprotection & Cognitive Function KPV: Reduces neuroinflammation, potentially benefiting conditions like Alzheimers and multiple sclerosis
Hertzman reported that ten patients who suffered from hypertension and mood disorders (major depressive disorder or bipolar disorder) had improved mood with a combination of antidepressants and lisinopril, and no serious negative effects were reported by any of these patients while using lisinopril (209)
Interestingly, GLP-1 receptor agonists resist degradation by the enzyme DPP-4 (dipeptidyl peptidase-4), which usually breaks down natural GLP-1 and reduces its activity [4]
Surprisingly, we found that liraglutide could activate the PKA/CREB pathway and inhibit inflammation
Calorie restriction has been shown to significantly improve several measures of glucose metabolism and diabetic complication risk (Colman 2009
GLP-1 receptor agonists like Wegovy and Mounjaro show the highest efficacy in clinical trials